PERSPECTA

News from every angle

Results for "US FDA"

54 stories found

FDA Investigates Multiple Cyclosporiasis Outbreaks Across US, New Outbreak Linked to Unspecified Product
HealthYahoojerusalem-post25d ago2 sources

FDA Investigates Multiple Cyclosporiasis Outbreaks Across US, New Outbreak Linked to Unspecified Product

The FDA is investigating multiple cyclosporiasis outbreaks across the US, with a new announcement adding to cases reported in the Midwest, including Michigan and four other states, and a new outbreak now linked to an unspecified product. These outbreaks have resulted in hundreds of hospitalizations since May, prompting public health officials to advise on symptom identification.

FDA Retracts Cyclospora Finding in Taylor Farms Lettuce, Investigation Continues
BusinessbloombergNYTThe Guardian+11NPRcbccnbcnosmarketwatchBusiness InsiderYahoohindustan-times+3 more28d ago14 sources

FDA Retracts Cyclospora Finding in Taylor Farms Lettuce, Investigation Continues

The FDA has retracted its initial positive cyclospora test on Taylor Farms lettuce, stating the finding was a false positive. Despite the retraction, the FDA remains focused on Taylor Farms lettuce as a potential source for the cyclospora outbreak, leading to a recall and public concern about lettuce consumption.

US FDA Approves New Treatment for IgA Nephropathy
Healthmyjoyonline1mo ago

US FDA Approves New Treatment for IgA Nephropathy

The United States Food and Drug Administration (FDA) has approved Trutakna (atacicept-vymj), a first-in-class treatment developed by Vera Therapeutics, aimed at reducing proteinuria in adults with primary immunoglobulin A nephropathy.

Big Tobacco Benefits from US FDA Shake-Up
BusinessReutersYahoo2mo ago2 sources

Big Tobacco Benefits from US FDA Shake-Up

Big Tobacco companies have emerged favorably following a recent shake-up at the US Food and Drug Administration. This restructuring appears to have created a more advantageous regulatory environment for the industry.

US Appeals Court Limits Mail-Order Access to Abortion Pill
PoliticsAPReutersBBC+19NYTle-mondeThe GuardianCNNFox Newsnosruvaftonbladet+11 more3mo ago22 sources

US Appeals Court Limits Mail-Order Access to Abortion Pill

A US federal appeals court has temporarily blocked the mail delivery of the abortion pill mifepristone, limiting access to the medication nationwide. This ruling restricts how the pill can be dispensed, pending further legal review.

FDA Recalls 1.6 Million Eggs Over Salmonella Risk in Five US States
BusinessThe IndependentYahooTimes of India+1hindustan-times26d ago4 sources

FDA Recalls 1.6 Million Eggs Over Salmonella Risk in Five US States

The FDA has issued a recall for nearly 1.6 million dozen eggs from Midwest Poultry Services due to potential Salmonella contamination. The affected eggs were distributed across five US states, prompting health concerns amid a surge in stomach illness cases.

HLB Pep registers vasopressin API with US FDA
BusinessKorea Herald22d ago

HLB Pep registers vasopressin API with US FDA

HLB Pep announced that it has registered its vasopressin active pharmaceutical ingredient with the US Food and Drug Administration’s Drug Master File system, advancing its push into global peptide drug markets for treating septic shock.

US FDA proposes faster gene therapy development
TechnologyYahoo2mo ago

US FDA proposes faster gene therapy development

The U.S. Food and Drug Administration (FDA) has put forward a proposal to accelerate the development of gene therapies by leveraging existing scientific knowledge. This initiative aims to streamline the process for bringing new gene therapies to patients.

DOJ Drops Criminal Probe Against Fed Chair Jerome Powell
PoliticsAPReutersBBC+80bloombergNYTwsjFTle-mondewapoThe GuardianNPR+72 more3mo ago83 sources

DOJ Drops Criminal Probe Against Fed Chair Jerome Powell

The U.S. Justice Department has officially ended its criminal investigation into Federal Reserve Chair Jerome Powell, clearing him of any wrongdoing. This decision comes amid discussions surrounding potential nominations for the Federal Reserve.

Yuhan's Gaucher Drug Candidate Receives FDA Orphan Status
HealthKorea Herald4mo ago

Yuhan's Gaucher Drug Candidate Receives FDA Orphan Status

Yuhan Corp.'s investigational drug YH35995 has been granted orphan drug designation by the US FDA for the treatment of Gaucher disease, a rare condition. This designation supports therapies for rare diseases with limited treatment options.